inappropri platelet agree create cardiovascular risk lang manga thienopyridin aspirin although effect drug carry risk increase bleed drug resist undermine drive new antiplatelet agent disco one strategy identify suitable druggabl target find small molecule model good exploit collagen receptor give promote thrombu format inhibitor safe bioavail dock fdaapprov library collagenbind site silicon report losartan cinanserin inhibit gpvimedi active select competed dosedepend manner meghan action like undermine cardioprotect effect could ascribe antihypertens therefore identify molecule also demons until structures repurposed 